PolyPeptide Group AG
A CDMO specializing in peptide and oligonucleotide-based active pharmaceutical ingredients.
PPGN | SW
Overview
Corporate Details
- ISIN(s):
- CH1110760852
- LEI:
- 5067007JCKTPOX4G9758
- Country:
- Switzerland
- Address:
- Neuhofstrasse 24, 6340 Baar
- Website:
- https://www.polypeptide.com/
- Sector:
- Manufacturing
Description
PolyPeptide Group AG is a Contract Development & Manufacturing Organization (CDMO) specializing in peptide- and oligonucleotide-based active pharmaceutical ingredients (APIs). The company serves the pharmaceutical and biotech sectors by providing a comprehensive range of services that cover all stages of product development, from pre-clinical to commercial manufacturing. Its offerings include both proprietary (custom) and generic GMP-grade peptides. PolyPeptide focuses on innovation in peptide synthesis and manufacturing processes to support the development of therapies for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-12 07:00 |
PolyPeptide and Lupin Manufacturing Solutions Form Strategic Alliance to Meet G…
|
English | 9.9 KB | ||
| 2025-12-12 01:00 |
PolyPeptide and Lupin Manufacturing Solutions Form Strategic Alliance to Meet G…
|
English | 8.2 KB | ||
| 2025-09-22 07:00 |
PolyPeptide Group achieves significant milestone in Malmo expansion project
|
English | 10.6 KB | ||
| 2025-09-22 02:00 |
PolyPeptide Group achieves significant milestone in Malmö expansion project
|
English | 8.5 KB | ||
| 2025-08-12 06:55 |
PolyPeptide delivers +24% growth in H1 2025, successful ramp-up at its Belgian …
|
English | 31.7 KB | ||
| 2025-08-12 02:00 |
PolyPeptide delivers +24% growth in H1 2025, successful ramp-up at its Belgian …
|
English | 28.4 KB | ||
| 2025-08-12 02:00 |
PolyPeptide wächst im ersten Halbjahr 2025 um 24%, mit einer erfolgreichen Anla…
|
German | 32.6 KB | ||
| 2025-05-23 07:00 |
PolyPeptide announces expansion of existing credit facilities
|
English | 7.8 KB | ||
| 2025-05-23 02:00 |
PolyPeptide announces expansion of existing credit facilities
|
English | 6.0 KB | ||
| 2025-05-23 02:00 |
PolyPeptide gibt Ausweitung des bestehenden Kreditrahmens bekannt
|
German | 7.0 KB | ||
| 2025-04-09 18:34 |
PolyPeptide announces results of the annual General Meeting 2025
|
English | 9.3 KB | ||
| 2025-03-19 07:00 |
PolyPeptide publishes invitation to the annual General Meeting 2025
|
English | 8.8 KB | ||
| 2025-03-18 07:00 |
PolyPeptide publishes invitation to the annual General Meeting 2025
|
English | 8.8 KB | ||
| 2025-03-18 01:00 |
PolyPeptide publishes invitation to the annual General Meeting 2025
|
English | 7.1 KB | ||
| 2025-03-18 01:00 |
PolyPeptide publiziert Einladung zur ordentlichen Generalversammlung 2025
|
German | 8.0 KB |
Automate Your Workflow. Get a real-time feed of all PolyPeptide Group AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PolyPeptide Group AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PolyPeptide Group AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-09 | N/A | Non-Executive member | Buy | None | 75,000.00 CHF |
| 2025-04-09 | N/A | Non-Executive member | Buy | None | 72,000.00 CHF |
| 2025-04-09 | N/A | Non-Executive member | Buy | None | 50,000.00 CHF |
| 2024-04-11 | N/A | Non-Executive member | Buy | None | 75,000.00 CHF |
| 2024-04-11 | N/A | Non-Executive member | Buy | None | 72,000.00 CHF |
| 2024-04-11 | N/A | Non-Executive member | Buy | None | 50,000.00 CHF |
| 2024-04-11 | N/A | Non-Executive member | Buy | None | 35,000.00 CHF |
| 2023-11-10 | N/A | Executive member | Buy | None | 51,250.00 CHF |
| 2023-10-11 | N/A | Executive member | Buy | None | 2,876,348.62 CHF |
| 2023-10-10 | N/A | Executive member | Buy | None | 371,202.96 CHF |
Peer Companies
